Informed Consent for Comparative Effectiveness Research Should Include Risks of Standard Care.

The article discusses the author's claim that the informed consent that is needed for comparative effectiveness research (CER) should include disclosures about the risks associated with standard care interventions, and it mentions risks of research and oversight by the U.S. Office for Human Research Protections (OHRP). Regulations to protect human subjects are examined, along with the medical research ethics, the Nuremberg Code, and American common law protections for individuals.